Human Embryonic Stem Cells Do Not Change Their X Inactivation Status during Differentiation

Cell Reports

Volumn 18, Issue 1, 2017, Pages 54-67

  Patel, Sanjeet ^a   Bonora, Giancarlo ^a   Sahakyan, Anna ^a   Kim, Rachel ^a   Chronis, Constantinos ^a   Langerman, Justin ^a   Fitz Gibbon, Sorel ^b   Rubbi, Liudmilla ^b   Skelton, Rhys J P ^a   Ardehali, Reza ^a   Pellegrini, Matteo ^b   Lowry, William E ^b   Clark, Amander T ^b   Plath, Kathrin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

DNA methylation; human embryonic stem cells; human induced pluripotent stem cells; inactive X chromosome; X chromosome dosage compensation; X inactivation; Xi erosion; Xist

Indexed keywords

ARTICLE; CELL DIFFERENTIATION; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DNA METHYLATION; EMBRYO; EMBRYONIC STEM CELL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LIMIT OF QUANTITATION; PRIORITY JOURNAL; RNA GENE; UPREGULATION; X CHROMOSOME INACTIVATION; XIST GENE; CELL LINE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HUMAN EMBRYONIC STEM CELL; INDUCED PLURIPOTENT STEM CELL; MALE; METABOLISM; SEQUENCE ANALYSIS;

RETINOIC ACID;

CELL DIFFERENTIATION; CELL LINE; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN EMBRYONIC STEM CELLS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INDUCED PLURIPOTENT STEM CELLS; MALE; SEQUENCE ANALYSIS, RNA; TRETINOIN; X CHROMOSOME INACTIVATION;

EID: 85007553587     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.11.054     Document Type: Article

References (34)

1. Anguera, M.C., Sadreyev, R., Zhang, Z., Szanto, A., Payer, B., Sheridan, S.D., Kwok, S., Haggarty, S.J., Sur, M., Alvarez, J., et al. Molecular signatures of human induced pluripotent stem cells highlight sex differences and cancer genes. Cell Stem Cell 11 (2012), 75–90.
2. Augui, S., Nora, E.P., Heard, E., Regulation of X-chromosome inactivation by the X-inactivation centre. Nat. Rev. Genet. 12 (2011), 429–442.
3. Balaton, B.P., Cotton, A.M., Brown, C.J., Derivation of consensus inactivation status for X-linked genes from genome-wide studies. Biol. Sex Differ., 6, 2015, 35.
4. Barakat, T.S., Ghazvini, M., de Hoon, B., Li, T., Eussen, B., Douben, H., van der Linden, R., van der Stap, N., Boter, M., Laven, J.S., et al. Stable X chromosome reactivation in female human induced pluripotent stem cells. Stem Cell Reports 4 (2015), 199–208.
5. Bock, C., Kiskinis, E., Verstappen, G., Gu, H., Boulting, G., Smith, Z.D., Ziller, M., Croft, G.F., Amoroso, M.W., Oakley, D.H., et al. Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 144 (2011), 439–452.
6. Davidson, K.C., Mason, E.A., Pera, M.F., The pluripotent state in mouse and human. Development 142 (2015), 3090–3099.
7. Disteche, C.M., Dosage compensation of the sex chromosomes. Annu. Rev. Genet. 46 (2012), 537–560.
8. Hall, L.L., Byron, M., Butler, J., Becker, K.A., Nelson, A., Amit, M., Itskovitz-Eldor, J., Stein, J., Stein, G., Ware, C., Lawrence, J.B., X-inactivation reveals epigenetic anomalies in most hESC but identifies sublines that initiate as expected. J. Cell. Physiol. 216 (2008), 445–452.
9. Hoffman, L.M., Hall, L., Batten, J.L., Young, H., Pardasani, D., Baetge, E.E., Lawrence, J., Carpenter, M.K., X-inactivation status varies in human embryonic stem cell lines. Stem Cells 23 (2005), 1468–1478.
10. Jiang, J., Jing, Y., Cost, G.J., Chiang, J.C., Kolpa, H.J., Cotton, A.M., Carone, D.M., Carone, B.R., Shivak, D.A., Guschin, D.Y., et al. Translating dosage compensation to trisomy 21. Nature 500 (2013), 296–300.
11. Kim, K.Y., Hysolli, E., Tanaka, Y., Wang, B., Jung, Y.W., Pan, X., Weissman, S.M., Park, I.H., X Chromosome of female cells shows dynamic changes in status during human somatic cell reprogramming. Stem Cell Reports 2 (2014), 896–909.
12. Lengner, C.J., Gimelbrant, A.A., Erwin, J.A., Cheng, A.W., Guenther, M.G., Welstead, G.G., Alagappan, R., Frampton, G.M., Xu, P., Muffat, J., et al. Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations. Cell 141 (2010), 872–883.
13. Meissner, A., Gnirke, A., Bell, G.W., Ramsahoye, B., Lander, E.S., Jaenisch, R., Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis. Nucleic Acids Res. 33 (2005), 5868–5877.
14. Mekhoubad, S., Bock, C., de Boer, A.S., Kiskinis, E., Meissner, A., Eggan, K., Erosion of dosage compensation impacts human iPSC disease modeling. Cell Stem Cell 10 (2012), 595–609.
15. Nazor, K.L., Altun, G., Lynch, C., Tran, H., Harness, J.V., Slavin, I., Garitaonandia, I., Müller, F.J., Wang, Y.C., Boscolo, F.S., et al. Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives. Cell Stem Cell 10 (2012), 620–634.
16. O'Leary, T., Heindryckx, B., Lierman, S., van Bruggen, D., Goeman, J.J., Vandewoestyne, M., Deforce, D., de Sousa Lopes, S.M., De Sutter, P., Tracking the progression of the human inner cell mass during embryonic stem cell derivation. Nat. Biotechnol. 30 (2012), 278–282.
17. Okamoto, I., Patrat, C., Thépot, D., Peynot, N., Fauque, P., Daniel, N., Diabangouaya, P., Wolf, J.P., Renard, J.P., Duranthon, V., Heard, E., Eutherian mammals use diverse strategies to initiate X-chromosome inactivation during development. Nature 472 (2011), 370–374.
18. Pasque, V., Gillich, A., Garrett, N., Gurdon, J.B., Histone variant macroH2A confers resistance to nuclear reprogramming. EMBO J. 30 (2011), 2373–2387.
19. Plath, K., Fang, J., Mlynarczyk-Evans, S.K., Cao, R., Worringer, K.A., Wang, H., de la Cruz, C.C., Otte, A.P., Panning, B., Zhang, Y., Role of histone H3 lysine 27 methylation in X inactivation. Science 300 (2003), 131–135.
20. Pomp, O., Dreesen, O., Leong, D.F., Meller-Pomp, O., Tan, T.T., Zhou, F., Colman, A., Unexpected X chromosome skewing during culture and reprogramming of human somatic cells can be alleviated by exogenous telomerase. Cell Stem Cell 9 (2011), 156–165.
21. Sahakyan, A., Kim, R., Chronis, C., Sabri, S., Bonora, G., Theunissen, T.W., Kuoy, E., Langerman, J., Clark, A.T., Jaenisch, R., Plath, K., Human naïve pluripotent stem cells model X-chromosome dampening and X-inactviation. Cell Stem Cell, 20, 2017, 10.1016/j.stem.2016.10.006 Published online December 15, 2016.
22. Schulz, E.G., Heard, E., Role and control of X chromosome dosage in mammalian development. Curr. Opin. Genet. Dev. 23 (2013), 109–115.
23. Sharp, A.J., Stathaki, E., Migliavacca, E., Brahmachary, M., Montgomery, S.B., Dupre, Y., Antonarakis, S.E., DNA methylation profiles of human active and inactive X chromosomes. Genome Res. 21 (2011), 1592–1600.
24. Shen, Y., Matsuno, Y., Fouse, S.D., Rao, N., Root, S., Xu, R., Pellegrini, M., Riggs, A.D., Fan, G., X-inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations. Proc. Natl. Acad. Sci. USA 105 (2008), 4709–4714.
25. Silva, S.S., Rowntree, R.K., Mekhoubad, S., Lee, J.T., X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells. Proc. Natl. Acad. Sci. USA 105 (2008), 4820–4825.
26. Smith, Z.D., Chan, M.M., Humm, K.C., Karnik, R., Mekhoubad, S., Regev, A., Eggan, K., Meissner, A., DNA methylation dynamics of the human preimplantation embryo. Nature 511 (2014), 611–615.
27. Tchieu, J., Kuoy, E., Chin, M.H., Trinh, H., Patterson, M., Sherman, S.P., Aimiuwu, O., Lindgren, A., Hakimian, S., Zack, J.A., et al. Female human iPSCs retain an inactive X chromosome. Cell Stem Cell 7 (2010), 329–342.
28. Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S., Jones, J.M., Embryonic stem cell lines derived from human blastocysts. Science 282 (1998), 1145–1147.
29. Tomoda, K., Takahashi, K., Leung, K., Okada, A., Narita, M., Yamada, N.A., Eilertson, K.E., Tsang, P., Baba, S., White, M.P., et al. Derivation conditions impact X-inactivation status in female human induced pluripotent stem cells. Cell Stem Cell 11 (2012), 91–99.
30. Vallot, C., Ouimette, J.F., Makhlouf, M., Féraud, O., Pontis, J., Côme, J., Martinat, C., Bennaceur-Griscelli, A., Lalande, M., Rougeulle, C., Erosion of X chromosome inactivation in human pluripotent cells initiates with XACT coating and depends on a specific heterochromatin landscape. Cell Stem Cell 16 (2015), 533–546.
31. Ware, C.B., Wang, L., Mecham, B.H., Shen, L., Nelson, A.M., Bar, M., Lamba, D.A., Dauphin, D.S., Buckingham, B., Askari, B., et al. Histone deacetylase inhibition elicits an evolutionarily conserved self-renewal program in embryonic stem cells. Cell Stem Cell 4 (2009), 359–369.
32. Xie, P., Ouyang, Q., Leng, L., Hu, L., Cheng, D., Tan, Y., Lu, G., Lin, G., The dynamic changes of X chromosome inactivation during early culture of human embryonic stem cells. Stem Cell Res. (Amst.) 17 (2016), 84–92.
33. Yang, L., Kirby, J.E., Sunwoo, H., Lee, J.T., Female mice lacking Xist RNA show partial dosage compensation and survive to term. Genes Dev. 30 (2016), 1747–1760.
34. Zvetkova, I., Apedaile, A., Ramsahoye, B., Mermoud, J.E., Crompton, L.A., John, R., Feil, R., Brockdorff, N., Global hypomethylation of the genome in XX embryonic stem cells. Nat. Genet. 37 (2005), 1274–1279.